Burnett Patrick bought ARQT
November 6, 2025 · Form 4 insider transaction
Burnett Patrick bought 17,250 shares of Arcutis Biotherapeutics, Inc. at $3.64 per share, a transaction worth $62.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,250
Price
$3.64
Total value
$62.8K
InsiderBurnett Patrick
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 6, 2025
Filing dateNovember 10, 2025
Shares owned after115,575
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026.